These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Geier DA, Geier MR. Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046 [Abstract] [Full Text] [Related]
4. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis. Geier D, Geier MR. Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492 [Abstract] [Full Text] [Related]
6. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F. Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594 [Abstract] [Full Text] [Related]
9. Letter to the editor. The safety of thimerosal in newborn and infant vaccines. Thompson WW, DeStefano F, Chen R. Vaccine; 2004 Dec 02; 23(3):281-2. PubMed ID: 15530668 [No Abstract] [Full Text] [Related]
14. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Pediatrics; 2004 Sep 02; 114(3):584-91. PubMed ID: 15342825 [Abstract] [Full Text] [Related]
18. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism]. García-Fernández L, Hernández AV, Suárez Moreno V, Fiestas F. Rev Peru Med Exp Salud Publica; 2013 Apr 02; 30(2):268-74. PubMed ID: 23949514 [Abstract] [Full Text] [Related]